with stimulatory or inhibitory effects on hematopoiesis remains to be determined.
Interferon-a (IFN-a) has a well-defined beneficial role in the treatment of myeloproliferative diseases, including chronic myelogenous leukemia (CML),19 polycythemia vera,"' and essential thrombocythemia." Although the mechanism of a selective suppression of the malignant clone by IFN-a in subpopulations of CML patients is unclear, cytogenetic responses are clearly associated with the more frequent hematologic responses of CML patients," which can be explained by the myelosuppressive effect of IFN. Direct antiproliferative effects of IFNs on hematopoietic progenitors are well known.** However, the regulation of cytokine cascades by type-I IFNs, as recently observed for IL-8" and IL-l receptor antagonist (IL-lRA),24 might contribute to the role of IFN as an inhibitory agent of hematopoiesis.
In this study, we used human stromal cell cultures to evaluate the effects of IFN-a on the expression of cytokines that are involved in the regulation of hematopoiesis. We demonstrate that IFN-a substantially inhibits the production of cytokines with stimulatory activity on hematopoietic progenitors and additionally counteracts IL-I effects by inducing IL-I RA. These results indicate that the myelosuppressive effects of IFN-a are. at least, in part mediated by modulating the expression of hematopoietic growth factors.
MATERIALS AND METHODS

Materials.
rh-IFN-a 2b with a specific activity of 1.8 X 10" U/ mg was obtained from Essex Pharma (Miinchen, Germany). rh-GM-CSF was kindly provided by Sandoz AG (Numberg, Germany), rh-1L-la by Hoffmann La Roche (Nutley, NJ), and rh-TNF-a (6.6 X IO6 U/mg) by Knoll AG (Ludwigshafen, Germany). LPS was purchased from Sigma Chemicals (Deisenhofen, Germany), actinomycin-D and cycloheximide (CHX) from Merck, Inc (Darmstadt, Germany), 'H-thymidine (20 C i h m o l ) from DuPont (Bad Homburg, Germany), monoclonal anti-huGM-CSF antibody from Boehringer (Mannheim, Germany) and a3*P-labeled nucleotides from Amersham Buchler (Braunschweig, Germany).
Stromal cell culture. Bone marrow stromal cell cultures were essentially obtained as described previouslyz5 with some modifications." Briefly. bone marrow mononuclear cells, separated by centrifugation over Ficoll-Hypaque, were incubated at a cell density of rRNA from ethidium bromide-stained gel as loading 18s control.
(FCS), 10% horse serum, 1.0 pmol/L hydrocortisone (Sigma Chemicals), and the additives as described." In weekly intervals, cultures were fed by replacing 75% of the culture medium. When cultures were covered more than 80% by adherent cell, the primary cultures were treated with trypsin-EDTA (Biochrom, Berlin, Germany). Detached stromal cells were pooled and expanded in new culture flasks at a surface ratio of 1:5 in 75 cm' tissue flasks. The adherent cells were incubated under the same culture conditions until the cultures became confluent again. By this culture method, homogenous stromal cell layers were obtained that were morphologically and functionally comparable in different culture flasks. Hydrocortisone was removed from these cultures at least 3 days before use for RNA and protein analysis. The viability of stromal cells after IFN treatment for 24 hours was evaluated by counting the viable cells after detachment by trypsinEDTA and staining with trypan blue. IFN-a was shown to have no effect on the viability of stromal cells under these conditions. GM-CSF, granulocyte-colony-stimulating factor (G-CSF), and IL-IRA were measured in the culture supernatants of stromal cells after incubation for 24 hours with various factors, as indicated in the Results section. Cell-associated IL-10 was measured in cell lysates of the same cultures. For preparation of cell lysates, stromal cells were washed three times with phosphate-buffered saline (PBS) and scraped from the culture flasks. The detached cells were resuspended in 1 .0 mL supplemented RPM1 1640 and sonified two times for 10 seconds using an ultrasound sonifier. Cell debris was removed by centrifugation, and the supernatant was used for IL-ID measurement. For RNA analysis, the factors as indicated in the Results section were added to parallel culture flasks from the same donor. After 6 hours the cells were lysed directly in the culture flask with guanidium-isothiocyanate lysis buffer and processed as described below. The content of a 75 cm' tissue flask yielded 10 to 20 pg total RNA.
Norrhern blot ana/vsis. Total cytoplasmic RNA was prepared using the single step method of guanidiniumlphenol-chloroform extraction as described previously." Ten to IS pg RNA (depending on the least yield obtained in each experiment) were subjected to electrophoresis on a 1 % agarose-formaldehyde gel and transferred onto nylon membrane (Hybond-N. Amersham Buchler). Blots were hybridized to d'P-labeled cDNA probes using random primer DNA labeling kit (Boehringer), washed, and exposed to Cronex-4 autoradiography films (DuPont) at -70°C. hu-GM-CSF cDNA, an 800-bp EcoRI fragment cloned into P91023(B)-vector. and hu-IL-ID cDNA, a 600-bp BurnHI fragment in YEpsecI-vector, were obtained from American Type Culture Collection (Rockville, MD). A cDNA probe for IL-IRA was prepared by polymerase chain reaction (PCR) amplification from RNA obtained from peripheral blood mononuclear cells (PBMNC) after reverse transcription using specific primer for IL-l RA, which resulted in a 492-bp fragment. Primer sequences: sense: S'ATGGAAATCTGCAGAGGCCTC3'. antisense: 5 ' T C -GTCAGGCATATTGGTGAGGCTGAC3'.'' Reverse transcription and PCR amplification were carried out as previously described.'x Enzyme-linked immunosorbent assay (ELISA): Concentrations of GM-CSF, G-CSF, IL-l RA, and IL-IP were measured using Quantikine Human Cytokine Immunoassays (R & D Systems, Minneapolis, MN) according to manufacturer's instructions. Sensitivity of the tests was as follows: GM-CSF 7.8 pglmL, G-CSF 31 pglmL, IL-ID 3.9 pglmL, and IL-l RA 31 pglmL.
/solotion qfhrtrnanforeskinJi/~roh/ost.s. Foreskin (obtained from the Division of Pediatrics, University of Mainz) was kept in 10% FCS/PBS for 30 minutes and subsequently washed in PBS. Epidermis was isolated from the foreskin using fine forceps and subsequently incubated in PBS supplemented with 2.5 UlmL dispase type I1 (Boehringer) at 37°C for 3 hours. After removal of dispase solution, foreskin was rinsed three times with PBS and incubated Confluent secondary stromal cultures were incubated in medium containing 100 U/mL IL-la with or without 1,000 U/mL IFN-a for 24 hours, and the cytokine concentration in the supernatants was assessed using specific ELISAs. Single experiments were carried out in triplicate, and data from five experiments are summarized as mean ? SEM.
sion was obtained by filtering the suspension through a stainless steel mesh. The residual dermal fragments were rinsed once with PBS/lO% FCS and discarded. Cells werc sedimented at 230g for 10 minutes at 4°C and washed twice with PBS/IO% FCS. Cells were incubated at IO"/mL in Iscove's medium. Subconfluent tirst passage fibroblasts were used for RNA experiments. The content of a 75 cmz tissue flask yielded 10 to 20 kg total RNA.
Proliferation ussuy. M07E cells were incubated in 96-well flat bottom microtiter plates either alone or on preformed stromal cell monolayers in supplemented RPM1 1640 + 10% FCS at 37"C/5% CO, with the factors indicated in the Results section. After 3 days, 1 pCi/well 'H-thymidine was added. Cells were harvested after 16 hours in a PHD-Cell Harvester (Dum Labortechnik, Asbach, Germany) and thymidine incorporation was quantified in a P-counter (Beckmann Munich, Germany).
RESULTS
Regulation of cytokine nzRNA expression by IFN-a. Expression of cytokine InRNA was examined in stromal cell cultures derived from five normal bone marrow samples. Multiple stromal cell cultures of individual donors were pooled after trypsinization and expanded in secondary cultures, to avoid heterogeneity of the cellular components and cell density. In such homogenous cultures, the mRNA expression of GM-CSF, IL-10, and 1L-IRA was examined in unstimulated stromal cells after addition of various stimuli. Low levels of constitutive expression of GM-CSF and TL-I/? were observed in two samples, whereas IL-1RA expression was never detected. The addition of IL-la, LPS, or TNF-a to stromal cell cultures induced the expression of Effects of IFN-a on the production of cell bound IL-1p and secreted IL-IRA. For IL-lp measurement, confluent secondary stromal cultures were incubated in medium with the indicated factors for 24 hours. Cells were lysed in 1 mL medium by sonifying, and ILIf3 concentration in the lysates was assessed using a specific ELISA.
IL-lb data represent mean 2 SEM from one typical experiment out of five, carried out in triplicate. IL-1RA was measured in supernatants of stromal cultures incubated for 24 hours in medium with or without IFN-a. Single experiments were carried out in triplicate and summarized data from five experiments are presented as mean ? SEM. Concentrations used were the same as indicated in the legend t o GM-CSF and IL-10 at different quantitative levels. The strongest signals were observed on stimulation with IL-la, followed by LPS and TNF-a. Expression of IL-1RA mRNA was only weakly induced by LPS and & l a , and observed only occasionally in the presence of TNF.
The influence of IFN-a on the expression of these cytokines was studied in exogenously stimulated stromal cell cultures. In stromal cells stimulated with IL-la, LPS, or TNF, the expression of GM-CSF and IL-10 was markedly inhibited at a concentration of ZEN-a 1,000 U/mL (Fig 1) . In contrast to the cytokines with stimulatory effects on hematopoiesis, IL-1RA mRNA was induced by IFN-cu at a much higher level as observed with LPS, suggesting a potent suppression of 1L-l mediated biologic actions. G-CSF expression, which was induced by IL-la and TNF, was also downregulated by IFN-a. However, the inhibitory effect was less pronounced as compared with GM-CSF and IL-10 (data not shown).
Effect of IFN-a on cytokine secretion by bone marrow stromal cells. Protein levels of GM-CSF, G-CSF, IL-10, and IL-1RA were evaluated in stromal cell supernatants using specific ELISAs. Unstimulated stromal cells failed to produce detectable levels of GM-CSF and G-CSF, and very low levels of IL-1RA were observed in only two of five experiments. In the presence of IL-la or LPS, significant amounts of GM-CSF or G-CSF were detected, whereas TNFa failed to induce G-CSF secretion and stimulated only very low levels of GM-CSF. IL-10 was never detected in stromal cell supernatants, independent of the stimulant added. The effect of IFN-a on the secretion of colony-stimulating factors was evaluated in cultures, which were stimulated with ILla (Fig 2) . Results obtained from five individual experiments showed a significant reduction of GM-CSF secretion by IFNa (1,000 U/mL) from 96.09 2 10.38 pg/mL to 28.2 2 6.91 pg/mL (mean 2 SEM), representing a reduction of 72.42% 2 10.38%. The reduction of G-CSF secretion by IFN-a was less pronounced and amounted to 40% (Fig 2B) .
Because IL-10 was not detected in stromal cell supernatants, despite readily detectable mRNA expression, we evaluated cell-associated IL-10 in stromal cell lysates. In fact, in cell lysates prepared by sonification of stromal cells, IL-10 production was seen on stimulation with either TNF, IL- (Fig 3A) . In such induced cultures, cell-associated IL-1P was induced at comparable levels. Addition of IFN-a drastically reduced cell-associated IL-1 p independent of the stimulus used, as shown in Fig 3A in one representative experiment. In four independent experiments, the mean reduction of IL-10 production by IFN-a in 1L-la stimulated stromal cells was 68% ? 14% (mean ? SEM). The strong induction of IL-1RA by IFN-a, as indicated by the mRNA plates with or without preformed stromal layers with the indicated factors, and a proliferation assay was carried out as described in Materials and Methods. Six experiments were carried out in triplicate and data from all experiments are summarized as mean * SEM. Concentrations used: IFN-a 1,000 U/ ml, IL-la 100 Ulml, GM-CSF 50 Ulml.
analysis, was confirmed at the protein level ( Fig  3B) . TFNa caused a more than 30-fold increase of IL-IRA secretion as compared with unstimulated cultures. In the presence of LPS, IL-la, or TNF no additive effect was observed in the combination with IFN-a (data not shown).
The dose dependence of the modulatory effects of cytokine secretion by IFN-a was evaluated at TFN concentrations between 10 and 10,000 U/mL (Fig 4) . Apparently, GM-CSF (Fig 4A) and IL-1RA (Fig 4D) secretion was most sensitive to the IFN-a action. However, significant effects of IFN-a were seen at concentrations of 10 to l00 U/mL for all cytokines evaluated in this study.
Biologic significance of IFN-a-mediated downregulution of GM-CSF. The consequences of the downregulation of hematopoietic growth factors by IFN-a were evaluated using the GM-CSF dependent cell line, M07e. As shown in Fig  5 , GM-CSF-induced proliferation of M07e cells cannot be inhibited by IFN-a. Furthermore, IFN-a failed to induce expression of the Mx gene, confirming the IFN resistance of this cell line (data not shown). TL-1 a had no direct proliferative effects on M07e cells, neither alone, nor in combination with GM-CSF (Fig 5 and data not shown) . When M07e cells were incubated in confluent stromal cultures, a moderate proliferation was observed without stimulation with an additional growth factor, which was presumably mediated by stromal cell derived growth factors. The addition of ILla to the stromal cultures, resulting in the induction of GM-CSF, caused an increase of thymidine incorporation in M07e cells, which was comparable to that induced by GM-CSF. IFN-a partially inhibited the indirect stimulation of M07e cells by IL-la in stromal cell cultures (Fig 5) . To prove that GM-CSF represents the stimulatory factor for M07e cells produced by stromal cells, a neutralizing antibody against GM-CSF was used in conditioned media from stromal cultures. M07e cells were incubated with stromal cell supernatants stimulated and, as a control, with GM-CSF or IL-3. IFN-cr (lanes 1 to 3) . or were pretreated with the first factor as indicated for 3 hours and supplemented with the second factor for a further 3 hours (indicated by arrows). Subsequently, cells were lysed and subjected to Northern-blot analysis. Concentrations used: IFN-a 1,000 U/mL, 11-1cr 100 UlmL, CHX 10 pg/mL.
Anti-GM-CSF antibody completely inhibited GM-CSF-induced but not IL-3-induced proliferation of M07e cells (Fig  6) . 1L-la-induced stroma supernatants induced proliferation comparable to GM-CSF, which was completely blocked by the antibody, clearly suggesting that GM-CSF is the stimulatory cytokine in the conditioned medium. Similar results were obtained when M07e cells were cocultured on IL-la stimulated stromal layers and anti-GM-CSF antibody was added (data not shown). Based on the resistance of M07e cells to a direct antiproliferative effect of IFN-a, it can be assumed that in stromal cell cultures the inhibition of M07e cells by IFN-a is mediated by the downregulation of stimulatory cytokines, such as GM-CSF.
Requirement of protein synthesis for IFN-a action. In experiments using CHX as an inhibitor of protein synthesis, a different pattern of gene expression was observed for ILIo and GM-CSF in response to IFN-a. When CHX was added simultaneously with IL-la, upregulation of both cytokines was prevented, suggesting that de novo protein synthesis was required for IL-Ia-mediated cytokine induction (data not shown). In IL-la-stimulated cultures, the addition of 41 47 IFN-a after three hours still resulted in a strong inhibition of GM-CSF expression, as was the case when IFN-a was added first, followed by IL-la (Fig 7) . Therefore, IL-la was added first, followed by CHX with or without IFN-a added 3 hours later. As shown in Fig 7, CHX caused a superinduction of GM-CSF mRNA expression, which was clearly downregulated by IFN-a. For the upregulation of IL-IRA by IFN-a, protein synthesis was not required. By contrast. IFN effects on IL-Io expression appeared to be mediated by a different mechanism. In comparison to cultures receiving IL-la and IFN-a simultaneously or IL-la after IFN-a, the downregulation of IL-Io expression was less pronounced when IL-la was added first, followed by IFN-a 3 hours later. In the presence of CHX, IFN-a failed to inhibit IL-Io expression suggesting that protein neosynthesis was necessary for this inhibitory effect of IFN-a.
Infruence of actinomycin D on downregulation of cytokine gene expression. For the RNA decay analysis, foreskin fibroblasts were used, which responded to IFN-a by downregulation of GM-CSF and IL-Io expression, as observed in bone marrow stromal cells (data not shown). When the RNA synthesis was inhibited by actinomycin D, the addition of IFN-a did not result in an enhanced decay of GM-CSF or IL-Io mRNA, suggesting that a posttranscriptional mechanism was not involved in the inhibitory effect of IFN-a on the expression of these cytokines (Fig 8) . Hematopoietic cytokines are important mediators of stromal cell-supported hematopoiesis in vitro and probably also in vivo. Although GM-CSF is rarely detected in the supernatant of unstimulated Dexter stroma, in several reports constitutive production of biologically active GM-CSF is described within the adherent layer,"." which is bound to glycosaminoglycans.3" Thus, inhibition of stromal cell-dependent hematopoiesis appears to be a logical consequence of IFNinduced downregulation of colony stimulating factors.
IL-l and IL-6 directly act on immature progenitor cells by a synergistic activity with colony-stimulating factors,"
formerly described as hemopoietin-I effect."." In addition, IL-I is a potent stimulant of GM-CSF and IL-6 production, leading to enhanced hematopoiesis in human long-term cultures."' Therefore, the inhibition of IL-10 and the concomitant induction of IL-IRA in bone marrow stromal cells by IFN-a are expected to counteract both the direct and the GM-CSF-mediated hematopoietic activity of IL-1. Although IL-I,B mRNA was readily detectable in induced stromal cells, we failed to detect 1L-I@ protein in stromal cell supernatants. Most studies on cytokine production in bone marrow stromal cells examined mRNA expression only" or used concentrated supernatants?" to detect IL-l protein. After lysis of stromal cells by sonification, significant levels of immunoreactive IL-10 were measured in the present study, suggesting that cell-associated IL-ID is the predominant species of this protein in bone marrow stroma.
Suppression of IL-10 production, which was induced by IL-la in monocytes, has recently been described for IFN--/ and IFN-a. However, in monocytic cells, IFN-a failed to suppress LPS-mediated IL-I expression.?' Interestingly, in bone marrow stromal cells, IFN-(U significantly inhibited both cytokine-and endotoxin-stimulated IL-ID production, suggesting that the mechanism of IFN-a to regulate cytokine cascades might be different in hematopoietic and stromal cells.
The biologic significance of IFN-a mediated suppression of hematopoietic growth factors was evaluated using the factor dependent cell line, M07e. In conventional long-term cultures IFN-a inhibits the proliferation of hematopoietic progenitors.36 However, it would be impossible to distinguish whether IFN-a suppresses long-term hematopoiesis predominantly by direct antiproliferative effects or by indirect antihematopoietic effects, due to the downregulation of hematopoietic growth factors. Therefore, a factor-dependent cell The biologic importance of this novel action by IFN-(U for the regulation of hematopoiesis in vivo is unclear. It can be assumed, however, that myelosuppressive effects of I F Na, as observed in therapeutic administration or during viral infection, might be at least partially based on the inhibition of the paracrine production of hematopoietic growth factors. Downregulation of hematopoietic cytokines might contribute to the beneficial effect of IFN-a in CML. The reduction of the paracrine secretion of hematopoietic growth factors, which appears to be enhanced by a constitutive overexpression of IL-I in some patients,"' might result in an overbalance of negative regulatory cytokines in the bone marrow microenvironment. Thus, in combination with other biologic actions, the influence of IFN-a on cytokine synthesis might contribute to the suppression of the malignant clone by IFNa in the early phase of the disease. Significant inhibition of GM-CSF and IL-IP production, as well as induction of IL-
